Search

everythinglearnresearchcommunity

for

Search:↓

The keratin 5 mutation in a family with epidermolysis bullosa simplex was due to mosaicism, not a new mutation.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

VEGF stimulates hair cell growth and increases growth receptor levels through a specific signaling pathway.

The EDAR gene mutation leads to thinner and more deformed hair shafts.

The mutation causes hairless mice due to mislocalized and dysfunctional HR protein.

Mice with human-like EGFR had growth issues, skin defects, heart problems, and unusual bone development.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

A 12-year-old girl was misdiagnosed with alopecia areata but actually had a nevus sebaceus with a genetic mutation.

VEGFR-2 is active in hair follicles, sebaceous glands, sweat glands, and skin on the human scalp.

A new gene mutation causes vitamin D-resistant rickets and hair loss in two siblings.

Fibroblasts from healthy donors can prevent changes seen in recessive epidermolysis bullosa simplex.

ILC1-like cells can cause alopecia areata by themselves.

New gene mutations linked to skin conditions were found, bacteria and chemicals may worsen acne, a dog mutation could exist in humans, virus-like elements might be involved in psoriasis, and a vitamin D3 treatment doesn't prevent chemotherapy-related hair loss.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

New mutations in the hairless gene may cause hair loss and affect bone development.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

HPV8 causes skin cancer by expanding specific skin stem cells.

Blocking EGFR in mice causes hair loss and skin changes.

Low ERCC3 gene activity is linked to non-pigmented hair growth.

Laser therapy on human skin affects the HERC6 gene and related genes, influencing many cell processes and requiring careful safety measures.

XEDAR triggers a specific signaling pathway in cells.

A new therapy for a skin blistering condition has not been developed yet.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

A new genetic mutation in mice causes permanent hair loss and skin wrinkling.